Global CRISPER-associated Nucleases Market Research Report 2023

Global CRISPER-associated Nucleases Market Research Report 2023

Table of Contents
1 CRISPER-associated Nucleases Market Overview
1.1 Product Overview and Scope of CRISPER-associated Nucleases
1.2 CRISPER-associated Nucleases Segment by Type
1.2.1 Global CRISPER-associated Nucleases Market Value Comparison by Type (2023-2029)
1.2.2 CRISPER-associated Protein 9 (Cas 9)
1.2.3 Cpf 1
1.2.4 CRISPER-associated Protein 13 (Cas 13)
1.3 CRISPER-associated Nucleases Segment by Application
1.3.1 Global CRISPER-associated Nucleases Market Value by Application: (2023-2029)
1.3.2 DNA Editing
1.3.3 RNA Editing
1.4 Global CRISPER-associated Nucleases Market Size Estimates and Forecasts
1.4.1 Global CRISPER-associated Nucleases Revenue 2018-2029
1.4.2 Global CRISPER-associated Nucleases Sales 2018-2029
1.4.3 Global CRISPER-associated Nucleases Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CRISPER-associated Nucleases Market Competition by Manufacturers
2.1 Global CRISPER-associated Nucleases Sales Market Share by Manufacturers (2018-2023)
2.2 Global CRISPER-associated Nucleases Revenue Market Share by Manufacturers (2018-2023)
2.3 Global CRISPER-associated Nucleases Average Price by Manufacturers (2018-2023)
2.4 Global CRISPER-associated Nucleases Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of CRISPER-associated Nucleases, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CRISPER-associated Nucleases, Product Type & Application
2.7 CRISPER-associated Nucleases Market Competitive Situation and Trends
2.7.1 CRISPER-associated Nucleases Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CRISPER-associated Nucleases Players Market Share by Revenue
2.7.3 Global CRISPER-associated Nucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CRISPER-associated Nucleases Retrospective Market Scenario by Region
3.1 Global CRISPER-associated Nucleases Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global CRISPER-associated Nucleases Global CRISPER-associated Nucleases Sales by Region: 2018-2029
3.2.1 Global CRISPER-associated Nucleases Sales by Region: 2018-2023
3.2.2 Global CRISPER-associated Nucleases Sales by Region: 2024-2029
3.3 Global CRISPER-associated Nucleases Global CRISPER-associated Nucleases Revenue by Region: 2018-2029
3.3.1 Global CRISPER-associated Nucleases Revenue by Region: 2018-2023
3.3.2 Global CRISPER-associated Nucleases Revenue by Region: 2024-2029
3.4 North America CRISPER-associated Nucleases Market Facts & Figures by Country
3.4.1 North America CRISPER-associated Nucleases Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America CRISPER-associated Nucleases Sales by Country (2018-2029)
3.4.3 North America CRISPER-associated Nucleases Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe CRISPER-associated Nucleases Market Facts & Figures by Country
3.5.1 Europe CRISPER-associated Nucleases Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe CRISPER-associated Nucleases Sales by Country (2018-2029)
3.5.3 Europe CRISPER-associated Nucleases Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CRISPER-associated Nucleases Market Facts & Figures by Country
3.6.1 Asia Pacific CRISPER-associated Nucleases Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific CRISPER-associated Nucleases Sales by Country (2018-2029)
3.6.3 Asia Pacific CRISPER-associated Nucleases Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America CRISPER-associated Nucleases Market Facts & Figures by Country
3.7.1 Latin America CRISPER-associated Nucleases Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America CRISPER-associated Nucleases Sales by Country (2018-2029)
3.7.3 Latin America CRISPER-associated Nucleases Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CRISPER-associated Nucleases Market Facts & Figures by Country
3.8.1 Middle East and Africa CRISPER-associated Nucleases Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa CRISPER-associated Nucleases Sales by Country (2018-2029)
3.8.3 Middle East and Africa CRISPER-associated Nucleases Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CRISPER-associated Nucleases Sales by Type (2018-2029)
4.1.1 Global CRISPER-associated Nucleases Sales by Type (2018-2023)
4.1.2 Global CRISPER-associated Nucleases Sales by Type (2024-2029)
4.1.3 Global CRISPER-associated Nucleases Sales Market Share by Type (2018-2029)
4.2 Global CRISPER-associated Nucleases Revenue by Type (2018-2029)
4.2.1 Global CRISPER-associated Nucleases Revenue by Type (2018-2023)
4.2.2 Global CRISPER-associated Nucleases Revenue by Type (2024-2029)
4.2.3 Global CRISPER-associated Nucleases Revenue Market Share by Type (2018-2029)
4.3 Global CRISPER-associated Nucleases Price by Type (2018-2029)
5 Segment by Application
5.1 Global CRISPER-associated Nucleases Sales by Application (2018-2029)
5.1.1 Global CRISPER-associated Nucleases Sales by Application (2018-2023)
5.1.2 Global CRISPER-associated Nucleases Sales by Application (2024-2029)
5.1.3 Global CRISPER-associated Nucleases Sales Market Share by Application (2018-2029)
5.2 Global CRISPER-associated Nucleases Revenue by Application (2018-2029)
5.2.1 Global CRISPER-associated Nucleases Revenue by Application (2018-2023)
5.2.2 Global CRISPER-associated Nucleases Revenue by Application (2024-2029)
5.2.3 Global CRISPER-associated Nucleases Revenue Market Share by Application (2018-2029)
5.3 Global CRISPER-associated Nucleases Price by Application (2018-2029)
6 Key Companies Profiled
6.1 The Odin
6.1.1 The Odin Corporation Information
6.1.2 The Odin Description and Business Overview
6.1.3 The Odin CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.1.4 The Odin CRISPER-associated Nucleases Product Portfolio
6.1.5 The Odin Recent Developments/Updates
6.2 Origene
6.2.1 Origene Corporation Information
6.2.2 Origene Description and Business Overview
6.2.3 Origene CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Origene CRISPER-associated Nucleases Product Portfolio
6.2.5 Origene Recent Developments/Updates
6.3 Amsbio
6.3.1 Amsbio Corporation Information
6.3.2 Amsbio Description and Business Overview
6.3.3 Amsbio CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Amsbio CRISPER-associated Nucleases Product Portfolio
6.3.5 Amsbio Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific CRISPER-associated Nucleases Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck CRISPER-associated Nucleases Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Boai Nky Medical Holdings Ltd
6.6.1 Boai Nky Medical Holdings Ltd Corporation Information
6.6.2 Boai Nky Medical Holdings Ltd Description and Business Overview
6.6.3 Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Product Portfolio
6.6.5 Boai Nky Medical Holdings Ltd Recent Developments/Updates
6.7 Biocompare
6.6.1 Biocompare Corporation Information
6.6.2 Biocompare Description and Business Overview
6.6.3 Biocompare CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biocompare CRISPER-associated Nucleases Product Portfolio
6.7.5 Biocompare Recent Developments/Updates
6.8 BioLabs, Inc.
6.8.1 BioLabs, Inc. Corporation Information
6.8.2 BioLabs, Inc. Description and Business Overview
6.8.3 BioLabs, Inc. CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BioLabs, Inc. CRISPER-associated Nucleases Product Portfolio
6.8.5 BioLabs, Inc. Recent Developments/Updates
6.9 Inscripta
6.9.1 Inscripta Corporation Information
6.9.2 Inscripta Description and Business Overview
6.9.3 Inscripta CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Inscripta CRISPER-associated Nucleases Product Portfolio
6.9.5 Inscripta Recent Developments/Updates
6.10 Sherlock Biosciences
6.10.1 Sherlock Biosciences Corporation Information
6.10.2 Sherlock Biosciences Description and Business Overview
6.10.3 Sherlock Biosciences CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sherlock Biosciences CRISPER-associated Nucleases Product Portfolio
6.10.5 Sherlock Biosciences Recent Developments/Updates
6.11 Editas
6.11.1 Editas Corporation Information
6.11.2 Editas CRISPER-associated Nucleases Description and Business Overview
6.11.3 Editas CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Editas CRISPER-associated Nucleases Product Portfolio
6.11.5 Editas Recent Developments/Updates
6.12 CRISPR Therapeutics
6.12.1 CRISPR Therapeutics Corporation Information
6.12.2 CRISPR Therapeutics CRISPER-associated Nucleases Description and Business Overview
6.12.3 CRISPR Therapeutics CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CRISPR Therapeutics CRISPER-associated Nucleases Product Portfolio
6.12.5 CRISPR Therapeutics Recent Developments/Updates
6.13 Synthego
6.13.1 Synthego Corporation Information
6.13.2 Synthego CRISPER-associated Nucleases Description and Business Overview
6.13.3 Synthego CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Synthego CRISPER-associated Nucleases Product Portfolio
6.13.5 Synthego Recent Developments/Updates
6.14 Addgene
6.14.1 Addgene Corporation Information
6.14.2 Addgene CRISPER-associated Nucleases Description and Business Overview
6.14.3 Addgene CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Addgene CRISPER-associated Nucleases Product Portfolio
6.14.5 Addgene Recent Developments/Updates
6.15 IDT (Integrated DNA Technologies)
6.15.1 IDT (Integrated DNA Technologies) Corporation Information
6.15.2 IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Description and Business Overview
6.15.3 IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.15.4 IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Product Portfolio
6.15.5 IDT (Integrated DNA Technologies) Recent Developments/Updates
6.16 Horizon Discovery
6.16.1 Horizon Discovery Corporation Information
6.16.2 Horizon Discovery CRISPER-associated Nucleases Description and Business Overview
6.16.3 Horizon Discovery CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Horizon Discovery CRISPER-associated Nucleases Product Portfolio
6.16.5 Horizon Discovery Recent Developments/Updates
6.17 ToolGen
6.17.1 ToolGen Corporation Information
6.17.2 ToolGen CRISPER-associated Nucleases Description and Business Overview
6.17.3 ToolGen CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.17.4 ToolGen CRISPER-associated Nucleases Product Portfolio
6.17.5 ToolGen Recent Developments/Updates
6.18 GenScript
6.18.1 GenScript Corporation Information
6.18.2 GenScript CRISPER-associated Nucleases Description and Business Overview
6.18.3 GenScript CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.18.4 GenScript CRISPER-associated Nucleases Product Portfolio
6.18.5 GenScript Recent Developments/Updates
6.19 New England Biolabs (NEB)
6.19.1 New England Biolabs (NEB) Corporation Information
6.19.2 New England Biolabs (NEB) CRISPER-associated Nucleases Description and Business Overview
6.19.3 New England Biolabs (NEB) CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2018-2023)
6.19.4 New England Biolabs (NEB) CRISPER-associated Nucleases Product Portfolio
6.19.5 New England Biolabs (NEB) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CRISPER-associated Nucleases Industry Chain Analysis
7.2 CRISPER-associated Nucleases Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CRISPER-associated Nucleases Production Mode & Process
7.4 CRISPER-associated Nucleases Sales and Marketing
7.4.1 CRISPER-associated Nucleases Sales Channels
7.4.2 CRISPER-associated Nucleases Distributors
7.5 CRISPER-associated Nucleases Customers
8 CRISPER-associated Nucleases Market Dynamics
8.1 CRISPER-associated Nucleases Industry Trends
8.2 CRISPER-associated Nucleases Market Drivers
8.3 CRISPER-associated Nucleases Market Challenges
8.4 CRISPER-associated Nucleases Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global CRISPER-associated Nucleases Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global CRISPER-associated Nucleases Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global CRISPER-associated Nucleases Market Competitive Situation by Manufacturers in 2022
Table 4. Global CRISPER-associated Nucleases Sales (Kg) of Key Manufacturers (2018-2023)
Table 5. Global CRISPER-associated Nucleases Sales Market Share by Manufacturers (2018-2023)
Table 6. Global CRISPER-associated Nucleases Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global CRISPER-associated Nucleases Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market CRISPER-associated Nucleases Average Price (US$/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of CRISPER-associated Nucleases, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of CRISPER-associated Nucleases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CRISPER-associated Nucleases, Product Type & Application
Table 12. Global Key Manufacturers of CRISPER-associated Nucleases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CRISPER-associated Nucleases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPER-associated Nucleases as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CRISPER-associated Nucleases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global CRISPER-associated Nucleases Sales by Region (2018-2023) & (Kg)
Table 18. Global CRISPER-associated Nucleases Sales Market Share by Region (2018-2023)
Table 19. Global CRISPER-associated Nucleases Sales by Region (2024-2029) & (Kg)
Table 20. Global CRISPER-associated Nucleases Sales Market Share by Region (2024-2029)
Table 21. Global CRISPER-associated Nucleases Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global CRISPER-associated Nucleases Revenue Market Share by Region (2018-2023)
Table 23. Global CRISPER-associated Nucleases Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global CRISPER-associated Nucleases Revenue Market Share by Region (2024-2029)
Table 25. North America CRISPER-associated Nucleases Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America CRISPER-associated Nucleases Sales by Country (2018-2023) & (Kg)
Table 27. North America CRISPER-associated Nucleases Sales by Country (2024-2029) & (Kg)
Table 28. North America CRISPER-associated Nucleases Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America CRISPER-associated Nucleases Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe CRISPER-associated Nucleases Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe CRISPER-associated Nucleases Sales by Country (2018-2023) & (Kg)
Table 32. Europe CRISPER-associated Nucleases Sales by Country (2024-2029) & (Kg)
Table 33. Europe CRISPER-associated Nucleases Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe CRISPER-associated Nucleases Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific CRISPER-associated Nucleases Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific CRISPER-associated Nucleases Sales by Region (2018-2023) & (Kg)
Table 37. Asia Pacific CRISPER-associated Nucleases Sales by Region (2024-2029) & (Kg)
Table 38. Asia Pacific CRISPER-associated Nucleases Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific CRISPER-associated Nucleases Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America CRISPER-associated Nucleases Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America CRISPER-associated Nucleases Sales by Country (2018-2023) & (Kg)
Table 42. Latin America CRISPER-associated Nucleases Sales by Country (2024-2029) & (Kg)
Table 43. Latin America CRISPER-associated Nucleases Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America CRISPER-associated Nucleases Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa CRISPER-associated Nucleases Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa CRISPER-associated Nucleases Sales by Country (2018-2023) & (Kg)
Table 47. Middle East & Africa CRISPER-associated Nucleases Sales by Country (2024-2029) & (Kg)
Table 48. Middle East & Africa CRISPER-associated Nucleases Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa CRISPER-associated Nucleases Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global CRISPER-associated Nucleases Sales (Kg) by Type (2018-2023)
Table 51. Global CRISPER-associated Nucleases Sales (Kg) by Type (2024-2029)
Table 52. Global CRISPER-associated Nucleases Sales Market Share by Type (2018-2023)
Table 53. Global CRISPER-associated Nucleases Sales Market Share by Type (2024-2029)
Table 54. Global CRISPER-associated Nucleases Revenue (US$ Million) by Type (2018-2023)
Table 55. Global CRISPER-associated Nucleases Revenue (US$ Million) by Type (2024-2029)
Table 56. Global CRISPER-associated Nucleases Revenue Market Share by Type (2018-2023)
Table 57. Global CRISPER-associated Nucleases Revenue Market Share by Type (2024-2029)
Table 58. Global CRISPER-associated Nucleases Price (US$/Kg) by Type (2018-2023)
Table 59. Global CRISPER-associated Nucleases Price (US$/Kg) by Type (2024-2029)
Table 60. Global CRISPER-associated Nucleases Sales (Kg) by Application (2018-2023)
Table 61. Global CRISPER-associated Nucleases Sales (Kg) by Application (2024-2029)
Table 62. Global CRISPER-associated Nucleases Sales Market Share by Application (2018-2023)
Table 63. Global CRISPER-associated Nucleases Sales Market Share by Application (2024-2029)
Table 64. Global CRISPER-associated Nucleases Revenue (US$ Million) by Application (2018-2023)
Table 65. Global CRISPER-associated Nucleases Revenue (US$ Million) by Application (2024-2029)
Table 66. Global CRISPER-associated Nucleases Revenue Market Share by Application (2018-2023)
Table 67. Global CRISPER-associated Nucleases Revenue Market Share by Application (2024-2029)
Table 68. Global CRISPER-associated Nucleases Price (US$/Kg) by Application (2018-2023)
Table 69. Global CRISPER-associated Nucleases Price (US$/Kg) by Application (2024-2029)
Table 70. The Odin Corporation Information
Table 71. The Odin Description and Business Overview
Table 72. The Odin CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 73. The Odin CRISPER-associated Nucleases Product
Table 74. The Odin Recent Developments/Updates
Table 75. Origene Corporation Information
Table 76. Origene Description and Business Overview
Table 77. Origene CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 78. Origene CRISPER-associated Nucleases Product
Table 79. Origene Recent Developments/Updates
Table 80. Amsbio Corporation Information
Table 81. Amsbio Description and Business Overview
Table 82. Amsbio CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 83. Amsbio CRISPER-associated Nucleases Product
Table 84. Amsbio Recent Developments/Updates
Table 85. Thermo Fisher Scientific Corporation Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 88. Thermo Fisher Scientific CRISPER-associated Nucleases Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 93. Merck CRISPER-associated Nucleases Product
Table 94. Merck Recent Developments/Updates
Table 95. Boai Nky Medical Holdings Ltd Corporation Information
Table 96. Boai Nky Medical Holdings Ltd Description and Business Overview
Table 97. Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 98. Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Product
Table 99. Boai Nky Medical Holdings Ltd Recent Developments/Updates
Table 100. Biocompare Corporation Information
Table 101. Biocompare Description and Business Overview
Table 102. Biocompare CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 103. Biocompare CRISPER-associated Nucleases Product
Table 104. Biocompare Recent Developments/Updates
Table 105. BioLabs, Inc. Corporation Information
Table 106. BioLabs, Inc. Description and Business Overview
Table 107. BioLabs, Inc. CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 108. BioLabs, Inc. CRISPER-associated Nucleases Product
Table 109. BioLabs, Inc. Recent Developments/Updates
Table 110. Inscripta Corporation Information
Table 111. Inscripta Description and Business Overview
Table 112. Inscripta CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 113. Inscripta CRISPER-associated Nucleases Product
Table 114. Inscripta Recent Developments/Updates
Table 115. Sherlock Biosciences Corporation Information
Table 116. Sherlock Biosciences Description and Business Overview
Table 117. Sherlock Biosciences CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 118. Sherlock Biosciences CRISPER-associated Nucleases Product
Table 119. Sherlock Biosciences Recent Developments/Updates
Table 120. Editas Corporation Information
Table 121. Editas Description and Business Overview
Table 122. Editas CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 123. Editas CRISPER-associated Nucleases Product
Table 124. Editas Recent Developments/Updates
Table 125. CRISPR Therapeutics Corporation Information
Table 126. CRISPR Therapeutics Description and Business Overview
Table 127. CRISPR Therapeutics CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 128. CRISPR Therapeutics CRISPER-associated Nucleases Product
Table 129. CRISPR Therapeutics Recent Developments/Updates
Table 130. Synthego Corporation Information
Table 131. Synthego Description and Business Overview
Table 132. Synthego CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 133. Synthego CRISPER-associated Nucleases Product
Table 134. Synthego Recent Developments/Updates
Table 135. Addgene Corporation Information
Table 136. Addgene Description and Business Overview
Table 137. Addgene CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 138. Addgene CRISPER-associated Nucleases Product
Table 139. Addgene Recent Developments/Updates
Table 140. IDT (Integrated DNA Technologies) Corporation Information
Table 141. IDT (Integrated DNA Technologies) Description and Business Overview
Table 142. IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 143. IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Product
Table 144. IDT (Integrated DNA Technologies) Recent Developments/Updates
Table 145. Horizon Discovery Corporation Information
Table 146. Horizon Discovery Description and Business Overview
Table 147. Horizon Discovery CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 148. Horizon Discovery CRISPER-associated Nucleases Product
Table 149. Horizon Discovery Recent Developments/Updates
Table 150. ToolGen Corporation Information
Table 151. ToolGen Description and Business Overview
Table 152. ToolGen CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 153. ToolGen CRISPER-associated Nucleases Product
Table 154. ToolGen Recent Developments/Updates
Table 155. GenScript Corporation Information
Table 156. GenScript Description and Business Overview
Table 157. GenScript CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 158. GenScript CRISPER-associated Nucleases Product
Table 159. GenScript Recent Developments/Updates
Table 160. New England Biolabs (NEB) Corporation Information
Table 161. New England Biolabs (NEB) Description and Business Overview
Table 162. New England Biolabs (NEB) CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 163. New England Biolabs (NEB) CRISPER-associated Nucleases Product
Table 164. New England Biolabs (NEB) Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. CRISPER-associated Nucleases Distributors List
Table 168. CRISPER-associated Nucleases Customers List
Table 169. CRISPER-associated Nucleases Market Trends
Table 170. CRISPER-associated Nucleases Market Drivers
Table 171. CRISPER-associated Nucleases Market Challenges
Table 172. CRISPER-associated Nucleases Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CRISPER-associated Nucleases
Figure 2. Global CRISPER-associated Nucleases Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global CRISPER-associated Nucleases Market Share by Type in 2022 & 2029
Figure 4. CRISPER-associated Protein 9 (Cas 9) Product Picture
Figure 5. Cpf 1 Product Picture
Figure 6. CRISPER-associated Protein 13 (Cas 13) Product Picture
Figure 7. Global CRISPER-associated Nucleases Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global CRISPER-associated Nucleases Market Share by Application in 2022 & 2029
Figure 9. DNA Editing
Figure 10. RNA Editing
Figure 11. Global CRISPER-associated Nucleases Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global CRISPER-associated Nucleases Market Size (2018-2029) & (US$ Million)
Figure 13. Global CRISPER-associated Nucleases Sales (2018-2029) & (Kg)
Figure 14. Global CRISPER-associated Nucleases Average Price (US$/Kg) & (2018-2029)
Figure 15. CRISPER-associated Nucleases Report Years Considered
Figure 16. CRISPER-associated Nucleases Sales Share by Manufacturers in 2022
Figure 17. Global CRISPER-associated Nucleases Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest CRISPER-associated Nucleases Players: Market Share by Revenue in 2022
Figure 19. CRISPER-associated Nucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global CRISPER-associated Nucleases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America CRISPER-associated Nucleases Sales Market Share by Country (2018-2029)
Figure 22. North America CRISPER-associated Nucleases Revenue Market Share by Country (2018-2029)
Figure 23. U.S. CRISPER-associated Nucleases Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada CRISPER-associated Nucleases Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe CRISPER-associated Nucleases Sales Market Share by Country (2018-2029)
Figure 26. Europe CRISPER-associated Nucleases Revenue Market Share by Country (2018-2029)
Figure 27. Germany CRISPER-associated Nucleases Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France CRISPER-associated Nucleases Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. CRISPER-associated Nucleases Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy CRISPER-associated Nucleases Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia CRISPER-associated Nucleases Revenue Growth Rate (2018-2029) & (US

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs